Recent developments in systems biology and genetic engineering toward design of vaccines for TB
October 12, 2021
Yogendra Singh, Gillian Beamer, Xingmin Sun, Pratyoosh Shukla
Crit Rev Biotechnol. 2021 Oct 12;1-16. doi: 10.1080/07388551.2021.1951649. Online ahead of print.
PMID: 34641752 | DOI: 10.1080/07388551.2021.1951649
Tuberculosis (TB) is one of the most prevalent diseases worldwide. The currently available Bacillus Calmette-Guérin vaccine is not sufficient in protecting against pulmonary TB. Although many vaccines have been evaluated in clinical trials, but none of them yet has proven to be more successful. Thus, new strategies are urgently needed to design more effective TB vaccines. The emergence of new technologies will undoubtedly accelerate the process of vaccine development. This review summarizes the potential and validated applications of emerging technologies, including: systems biology (genomics, proteomics, and transcriptomics), genetic engineering, and other computational tools to discover and develop novel vaccines against TB. It also discussed that the significant implementation of these approaches will play crucial roles in the development of novel vaccines to cure and control TB.